Patents by Inventor Nina Kaminen

Nina Kaminen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080241178
    Abstract: The present invention describes a novel human gene, DYXC1, which is functionally related to dyslexia. DYXC1 gene encodes a 420-amino acid residue protein. DYXC1 is expressed in several tissues, including the brain, and is localized in the nucleus. In addition, four single nucleotide polymorphisms (SNPs) in DYXC1 mRNA have been characterized in this invention. The invention provides diagnostic methods and materials for analysing allelic variation in DYSC1 gene. This invention also provides polypeptides encoded by DYXC1 gene and antibodies binding to said polypeptides.
    Type: Application
    Filed: March 10, 2008
    Publication date: October 2, 2008
    Applicant: Licentia Ltd.
    Inventors: Juha KERE, Mikko Taipale, Jaana Nopola-Hemmi, Nina Kaminen
  • Patent number: 7355022
    Abstract: The present invention describes a novel human gene, DYXC1, which is functionally related to dyslexia. DYXC1 gene encodes a 420-amino acid residue protein. DYXC1 is expressed in several tissues, including the brain, and is localized in the nucleus. In addition, four single nucleotide polymorphisms (SNPs) in DYXC1 mRNA have been characterized in this invention. The invention provides diagnostic methods and materials for analysing allelic variation in DYXC1 gene. This invention also provides polypeptides encoded by DYXC1 gene and antibodies binding to said polypeptides.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: April 8, 2008
    Assignee: Licentia Ltd.
    Inventors: Juha Kere, Mikko Taipale, Jaana Nopola-Hemmi, Nina Kaminen
  • Publication number: 20040138441
    Abstract: The present invention describes a novel human gene, DYXC1, which is functionally related to dyslexia. DYXC1 gene encodes a 420-amino acid residue protein. DYXC1 is expressed in several tissues, including the brain, and is localized in the nucleus. In addition, four single nucleotide polymorphisms (SNPs) in DYXC1 mRNA have been characterized in this invention. The invention provides diagnostic methods and materials for analysing allelic variation in DYXC1 gene. This invention also provides polypeptides encoded by DYXC1 gene and antibodies binding to said polypeptides.
    Type: Application
    Filed: October 9, 2003
    Publication date: July 15, 2004
    Inventors: Juha Kere, Mikko Taipale, Jaana Nopola-Hemmi, Nina Kaminen
  • Publication number: 20030219787
    Abstract: The present invention describes a novel human gene, DYXC1, which is functionally related to dyslexia. DYXC1 gene encodes a 420-amino acid residue protein. DYXC1 is expressed in several tissues, including the brain, and is localized in the nucleus. In addition, four single nucleotide polymorphisms (SNPs) in DYXC1 mRNA have been characterized in this invention. The invention provides diagnostic methods and materials for analysing allelic variation in DYXC1 gene. This invention also provides polypeptides encoded by DYXC1 gene and antibodies binding to said polypeptides.
    Type: Application
    Filed: February 12, 2003
    Publication date: November 27, 2003
    Inventors: Juha Kere, Mikko Taipale, Jaana Nopola-Hemmi, Nina Kaminen